Trial Profile
REN-1654 in sciatica: a phase 2, randomized, double-blind, placebo controlled, multi-center study in subjects with pain due to lumbosacral radiculopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2017
Price :
$35
*
At a glance
- Drugs REN 1654 (Primary)
- Indications Neuropathic pain; Sciatica
- Focus Therapeutic Use
- 21 Oct 2005 New trial record.